top of page
Screen Shot 2023-04-12 at 9.58.48 PM.png

INOPASE

EXPLORING A NEW WAY OF TREATING CHRONIC NEUROLOGICAL DISEASES 
THROUGH PERSONALIZED CLOSED-LOOP NEUROMODULATION

 

INOPASE empowers and supports people with chronic neurological diseases
to improve their quality of life

OUR CLOSED-LOOP NEUROMODULATION

Closed-loop neuromodulation is the key to restoring lost function by inducing neuroplasticity in the brain.


Our closed-loop neuromodulation has advanced algorithm to detect symptoms and provide dynamic stimulation therapy.

This innovative technology enables personalized treatment based on biological sensing, unlocking the full potential of your mind and body.

PROJECTS

An integrated solution that promises to revolutionize the way we diagnose and treat challenging diseases.

Closed-Loop

Sacral Neuromodulation

Imagine a breakthrough solution that could ease the burden on those struggling with overactive bladder, while increasing the chances of achieving long-awaited relief.

With the latest advancements in medical research, we can now offer a path to overactive bladder remission that is both effective and compassionate, helping patients take back control of their lives and achieve the freedom they deserve.

Closed-Loop

Brain Neuromodulation

Imagine a cutting-edge device that has the power to unlock new possibilities for those struggling with drug-resistant, intractable epilepsy.

By combining the latest advancements in technology with the insights of leading clinical experts, we are developing an integrated solution that promises to revolutionize the way we diagnose and treat this challenging condition. 

MEET THE TEAM

mune.jpg

MUNEMASA SUGIMOTO

Founder & CEO

• 10 years+ business experiences in healthcare industry (Novartis, CDI Medical)
• Project Assistant Professor at the University of Tokyo Hospital
• Japan BIODESIGN Innovation Fellow
• CPA experience (KPMG AZSA LLC.)
• MBA at Washington University in St. Louis, US

peter.jpg

WANG YEN PO

Founder & CTO

• 8 years+ experiences in wireless power and closed-loop stimulation development
• Ph.D student in Human Engineer at the University of Tokyo
• Japan BIODESIGN Innovation Fellow
• Fellowship at Innovation for Intelligent World
• BE Health Ventures, Japan PJ Lead

kumi.jpg

KUMI SAKURAI

CMO

• 15 years+ business and marketing experiences in medical device industry (Medtronic, Abbott, Danaher Corporation)
• Premo Partners, Inc., CEO
• Research Fellow at Keio univ. hospital
• MBA at Kanazawa Institute of Technology, Japan. Master at Waseda University, Japan

PARTNERS

Japan Agency for Medical Research and Development.png

Japan agency for medical research
and development

5R6FSIeZ_400x400.jpg

Tokyo Metropolitan
Small & Medium Entreprise Support Center

a2778_0.jpg

Japan External
Trade Organization

4842b9e7-3a79-415d-8f30-8deefb5ed4c8.png

B.E.
Accelerator

Screen Shot 2023-04-13 at 8.18.37 PM.png

C.P. Medical

p2YyZlyO_400x400.jpg

COFORCE Medical Inc.

images.png

LINK Medical Research

rogp.png

Tohoku University Hospital

itri_logo.png

Industrial Technology Research Institute

index-pic-index02-6.jpg.webp

Tokyo Institute of Technology

UnivOfTokyo_mark.svg.png

The University of Tokyo

YCU_Logo.png

Yokohama City University

Basic_RGB.png

Fukushima Medical University

Screen Shot 2023-04-13 at 8.20.02 PM.png

Dokkyo Medical University

Screen Shot 2023-04-13 at 8.33.00 PM.png

Nagano Prefectural
Shinshu Medical Center

Screen Shot 2023-04-13 at 8.39.13 PM.png

Marien Hospital
HerneUniversitätsklinikum der Ruhr-Universität Bochum

NEWS

2023.02.28

INOPASE obtained a Medical Device Manufacturing License

2023.02.28

INOPASE participated in the middleweight division of “GET IN THE RING OSAKA 2023 – Health Tech”

2023.02.28

INOPASE will participate in the 3rd Japan Biodesign Conference on March 3, 2023 (as a speaker and booth exhibitor)

2023.01.30

INOPASE will participate in JETRO Online Joint Company Information Session Winter 2023

2022.12.16 - 18

Wang Yen Po, CTO of INOPASE, has been selected for the 2022 Global to Outstanding Leadership Award in Healthcare and will attend the award ceremony at the Health 2.0 Conference (Dubai)

2022.10.26 - 27

INOPASE will participate in ASIAN ENTREPRENEURSHIP AWARD 2022 (AEA 2022)

2022.10.12 - 14

INOPASE will participate in Japan Healthcare Venture Summit 2022 (Pacifico Yokohama)

INOPASE was selected for the 2022 Foreign Patent Application Fee Subsidy Program

2022.09.28

INOPASE has been selected for the X-HUB TOKYO Outbound Program Germany Course (JETRO)

2022.09.28

INOPASE will participate in Japan Analytical & Scientific Instruments Show, JASIS 2022 (Makuhari Messe International Exhibition Hall)

2022.06.08

INOPASE obtained funding from Japan Agency for Medical Research and Development (AMED)

2021.11.16

INOPASE features on Business NEXT media in Taiwan, the Taiwan’s most influential technology and financial media

2021.11.16

INOPASE obtained grant from Japan Tokyo Government

2021.09.01

INOPASE won the Second winner in global competition at BME iDEA APAC 2021 Annual Summit

2021.08.16

INOPASE’s solution is being introduced by Taiwanese Urologist doctor

2021.08.16

INOPASE features on Yahoo Finance News: Witness 12 MedTech Startups Show the Latest Innovation of Healthcare

2021.06.24

INOPASE obtained funding from Japan Agency for Medical Research and Development (AMED)

GET IN TOUCH

Find us on Social Media!
  • Facebook
  • LinkedIn
bottom of page